Peter Orszag, CEO of Financial Advisory, Lazard, gestures with his left hand and speaks while sitting in front of a Milken Institute Global Conference projection — politics coverage from STAT
Peter Orszag, CEO of financial advisory firm Lazard.PATRICK T. FALLON/AFP via Getty Images

Peter Orszag was instrumental in crafting the Affordable Care Act. Now, he wants federal antitrust authorities to ease up on their sharp scrutiny of health care transactions that he acknowledges the law has encouraged — and that make a lot of money for his investment bank.

Orszag’s comments, made last week on TV, reveal how policymakers can end up profiting from the laws they help create. In this case, the biggest piece of health care legislation in the past half-century has been a fountain of wealth for the financial advisers that help hospitals, health insurers, and other large companies merge with each other.

advertisement

Orszag, the CEO of Lazard, served in President Barack Obama’s administration and was an architect of the ACA. He lamented last week how antitrust reviewers at Lina Khan’s Federal Trade Commission and Jonathan Kanter’s Antitrust Division at the Department of Justice are increasingly thwarting or stalling deals that have proliferated since the law went into effect in 2010. 

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe